[Corrections] Correction to Lancet Neurol 2026; 25: 115

The Lancet Neurology. The value of patient experience in multiple sclerosis research. Lancet Neurol 2026; 25: 115—In this Editorial, the third sentence of the second paragraph should have read “PROs have been used as primary endpoints for other neurological disorders, such as myasthenia gravis, but not multiple sclerosis, for reasons that include the historical reliance on other outcomes and the heterogeneous and fluctuating nature of the disease.” This correction has been made to the online version as of Jan 22, 2026.